CLINUVEL PHARMACEUTICALS LIMITED (CUVL) Total liabilities 2025–2026
CLINUVEL PHARMACEUTICALS LIMITED (CUVL) total liabilities at each fiscal year-end, per SEC filings.
$15.4MFY2026 · since FY2025: $20.0M → $15.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $15.4M | -23.2% |
| FY2025 | $20.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CUVL financial trends
CUVL RevenueCUVL Net incomeCUVL Net marginCUVL Gross profitCUVL Gross marginCUVL Operating incomeCUVL Operating marginCUVL Operating cash flowCUVL Free cash flowCUVL Capital expendituresCUVL Return on equityCUVL Stock buybacksCUVL Dividends paidCUVL Total assetsCUVL Shareholders’ equityCUVL overview →